Mark Iwicki

Insider Reports History

Location
Marlborough, MA
Signature
/s/ Mark Iwicki
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Iwicki:

Company Role Class Num Shares Value Price $ Report Date Ownership
Q32 Bio Inc. Director Stock Option (Right to Buy) 53,521 $342,666 $13.42 23 Oct 2025 Direct
KALA BIO, Inc. Director Common Stock 103,540 $212,257 $2.05 23 Oct 2025 Direct
Aerovate Therapeutics, Inc. Director Stock Option (Right to Buy) 12,500 $204,625 $16.37 05 Jun 2024 Direct
Merus N.V. Director Share Option (right to buy) 0 $119,571 $13.52 12 Dec 2025 Direct
Akero Therapeutics, Inc. Director Common Stock 0 $0 $54.31 09 Dec 2025 Direct
Merus N.V. Director Common Shares 0 $0 $97.00 12 Dec 2025 Direct
Third Harmonic Bio, Inc. Director Common Stock 0 $0 $41.00 11 Aug 2025 Direct
Inhibikase Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 4,982,706 05 Jan 2026 Direct
KALA BIO, Inc. Director Stock Option (right to buy) 5,450 15 Jun 2025 Direct
Akero Therapeutics, Inc. Director Stock Option (Right to Buy) 0 09 Dec 2025 Direct
Third Harmonic Bio, Inc. Director Stock Option 0 11 Aug 2025 Direct

Insider Reports Filed by Mark Iwicki

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IKT Inhibikase Therapeutics, Inc. 05 Jan 2026 1 $0 4 Chief Executive Officer, Director 07 Jan 2026, 16:23
MRUS Merus N.V. 12 Dec 2025 10 -$7,136,872 4 Director 12 Dec 2025, 18:52
AKRO Akero Therapeutics, Inc. 09 Dec 2025 9 $0 4 Director 09 Dec 2025, 10:14
QTTB Q32 Bio Inc. 23 Oct 2025 1 $0 4 Director 27 Oct 2025, 21:26
KALA KALA BIO, Inc. 23 Oct 2025 1 -$125,464 4 Director 24 Oct 2025, 20:00
THRD Third Harmonic Bio, Inc. 11 Aug 2025 2 $0 4 Director 14 Aug 2025, 16:06
KALA KALA BIO, Inc. 24 Jun 2025 1 -$53,040 4 Director 26 Jun 2025, 20:00
KALA KALA BIO, Inc. 15 Jun 2025 2 $0 4 Director 17 Jun 2025, 20:00
KALA KALA BIO, Inc. 03 Jun 2025 1 -$40,639 4/A Director 05 Jun 2025, 21:44
AKRO Akero Therapeutics, Inc. 03 Jun 2025 1 $0 4 Director 05 Jun 2025, 16:06
MRUS Merus N.V. 22 May 2025 1 $0 4 Director 27 May 2025, 08:00
QTTB Q32 Bio Inc. 24 Feb 2025 6 $0 4 Director 26 Feb 2025, 21:57
IKT Inhibikase Therapeutics, Inc. 21 Feb 2025 1 $0 4/A Chief Executive Officer, Director 02 Jul 2025, 19:56
IKT Inhibikase Therapeutics, Inc. 14 Feb 2025 2 $0 4 Chief Executive Officer, Director 19 Feb 2025, 20:26
IKT Inhibikase Therapeutics, Inc. 14 Feb 2025 0 $0 3 Chief Executive Officer, Director 19 Feb 2025, 20:24
KALA KALA BIO, Inc. 06 Jan 2025 3 -$44,094 4 CHIEF EXECUTIVE OFFICER, Director 07 Jan 2025, 20:12
KALA KALA BIO, Inc. 26 Jun 2024 1 -$72,048 4 CHIEF EXECUTIVE OFFICER, Director 27 Jun 2024, 20:00
AKRO Akero Therapeutics, Inc. 08 Jun 2024 1 $0 4 Director 11 Jun 2024, 17:28
THRD Third Harmonic Bio, Inc. 06 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:24
JBIO Aerovate Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 18:00
KALA KALA BIO, Inc. 31 May 2024 1 -$45,017 4 CHIEF EXECUTIVE OFFICER, Director 03 Jun 2024, 20:00
MRUS Merus N.V. 07 May 2024 1 $0 4 Director 09 May 2024, 16:30
QTTB Homology Medicines, Inc. 25 Mar 2024 1 $0 4 Director 27 Mar 2024, 17:40
QTTB Homology Medicines, Inc. 25 Mar 2024 0 $0 3 Director 27 Mar 2024, 17:16
KALA KALA BIO, Inc. 04 Jan 2024 3 -$30,547 4 CHIEF EXECUTIVE OFFICER, Director 05 Jan 2024, 16:04
AKRO Akero Therapeutics, Inc. 23 Jun 2023 1 $0 4 Director 27 Jun 2023, 17:39
KALA Kala Pharmaceuticals, Inc. 22 Jun 2023 2 $0 4 CHIEF EXECUTIVE OFFICER, Director 23 Jun 2023, 20:00
MRUS Merus N.V. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:16
JBIO Aerovate Therapeutics, Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 18:00
THRD Third Harmonic Bio, Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:18
KALA Kala Pharmaceuticals, Inc. 31 May 2023 11 $0 4 CHIEF EXECUTIVE OFFICER, Director 02 Jun 2023, 20:00
MRUS Merus N.V. 14 Apr 2023 4 +$534,679 4 Director 17 Apr 2023, 08:26
KALA Kala Pharmaceuticals, Inc. 14 Mar 2023 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 15 Mar 2023, 20:00
THRD Third Harmonic Bio, Inc. 06 Mar 2023 4 $0 4 Director 08 Mar 2023, 16:02
KALA Kala Pharmaceuticals, Inc. 04 Jan 2023 2 -$5,651 4 CHIEF EXECUTIVE OFFICER, Director 06 Jan 2023, 19:00
KALA Kala Pharmaceuticals, Inc. 26 Oct 2022 1 -$3,658 4 CHIEF EXECUTIVE OFFICER, Director 28 Oct 2022, 16:15
THRD Third Harmonic Bio, Inc. 26 Oct 2022 1 $0 4 Director 27 Oct 2022, 16:55
THRD Third Harmonic Bio, Inc. 14 Sep 2022 0 $0 3 Director 14 Sep 2022, 18:08
KALA Kala Pharmaceuticals, Inc. 27 Jun 2022 1 -$2,951 4 CHIEF EXECUTIVE OFFICER, Director 29 Jun 2022, 20:09
JBIO Aerovate Therapeutics, Inc. 21 Jun 2022 1 $0 4 Director 22 Jun 2022, 17:00
AKRO Akero Therapeutics, Inc. 02 Jun 2022 1 $0 4 Director 03 Jun 2022, 16:06
MRUS Merus N.V. 31 May 2022 1 $0 4 Director 02 Jun 2022, 16:05
KALA Kala Pharmaceuticals, Inc. 03 Jan 2022 2 -$12,373 4 CHIEF EXECUTIVE OFFICER, Director 05 Jan 2022, 19:00
KALA Kala Pharmaceuticals, Inc. 26 Oct 2021 1 -$49,676 4 CHIEF EXECUTIVE OFFICER, Director 28 Oct 2021, 20:01
JBIO Aerovate Therapeutics, Inc. 29 Jun 2021 0 $0 3 Director 29 Jun 2021, 19:41
KALA Kala Pharmaceuticals, Inc. 28 Jun 2021 1 -$43,771 4 CHIEF EXECUTIVE OFFICER, Director 29 Jun 2021, 17:25
AKRO Akero Therapeutics, Inc. 01 Jun 2021 1 $0 4 Director 03 Jun 2021, 17:58
MRUS Merus N.V. 28 May 2021 1 $0 4 Director 02 Jun 2021, 16:10
JBIO Aerovate Therapeutics, Inc. 02 Apr 2021 3 $0 4 Director 01 Jul 2021, 18:33